Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
Clinical trial NCT00911261 · COMPLETED
Trial details
- NCT number
- NCT00911261
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Primary completion
- 2005-03-01
- Enrollment
- 223
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.